Mariam Alexander: More Options for NSCLC with EGFR Exon 20 Insertion Mutation

Mariam Alexander, Thoracic Medical Oncologist at MUSC Health University Medical Center, shared a post on X:

“More options for this rare disease. Would this work after zipalertinib (trial patient)? FDA grants accelerated approval to sunvozertinib for NSCLC with EGFR exon 20 insertion mutation.”